Global Medical Cannabis Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Medicinal cannabis are also known as Medical marijuana, which area used either to treat disease or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures.
According to our (Global Info Research) latest study, the global Medical Cannabis market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The various economies are involved in the activities to legalize the export of medicinal cannabis product, which in turn is expected to fuel growth of the medical cannabis market.
This report is a detailed and comprehensive analysis for global Medical Cannabis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Medical Cannabis market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Medical Cannabis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Medical Cannabis market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Medical Cannabis market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/MT), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Cannabis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Cannabis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc and Canopy Growth Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Medical Cannabis market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Tetrahydrocannabinol (THC)
    Cannabidiol (CBD)
Market segment by Application
    Pain
    Arthritis
    Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)
    Others
Major players covered
    BOL Pharma
    Tilray
    Medreleaf Corporation
    Aurora Cannabis, Inc
    Canopy Growth Corporation
    Insys Therapeutics, Inc
    Aphria, Inc
    MGC Pharmaceuticals Limited
    GW Pharmaceuticals, plc
    Medical Marijuana Inc
    Medipharm Labs
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Cannabis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Cannabis, with price, sales, revenue and global market share of Medical Cannabis from 2018 to 2023.
Chapter 3, the Medical Cannabis competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Cannabis breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Medical Cannabis market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Cannabis.
Chapter 14 and 15, to describe Medical Cannabis sales channel, distributors, customers, research findings and conclusion.